DOCS Classe A Doximity, Inc. Class A Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 6, 2026DOCS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
DOCS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Doximity, Inc. Class A Common Stock Visão geral da empresa da Wikipedia
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck. In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California. By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list. In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year. In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones. In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. At the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site. In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million. Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones. In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries. In February 2022, Doximity acquired Amion, an on-call doctor scheduling company. In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | DOCS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 33.2média 5A ≈49.8 | ≈49.8 | · | · | |
| P/S (TTM) | 7.7média 5A ≈16.1 | ≈16.1 | · | · | |
| P/B (MRQ) | 5.5média 5A ≈7.6 | ≈7.6 | · | · | |
| Price / FCF (Preço / FCF) | 15.7média 5A ≈39.2 | ≈39.2 | · | · | |
| Price / Cash Flow (Preço / Fluxo de Caixa) | 15.7média 5A ≈38.9 | ≈38.9 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 5.7média 5A ≈8.3 | ≈8.3 | · | · | |
| PEG Ratio | ≈1.0 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | DOCS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 88.1%média 5A ≈88.9% | ≈88.9% | · | · | |
| Margem Operacional (TTM) | 29.6%média 5A ≈34.1% | ≈34.1% | · | · | |
| Margem EBITDA (TTM) | 32.0%média 5A ≈36.2% | ≈36.2% | · | · | |
| Margem de Impostos Pré-Tributação (TTM) | 34.5%média 5A ≈37.8% | ≈37.8% | · | · | |
| Margem de Lucro Líquido (TTM) | 25.5%média 5A ≈34.5% | ≈34.5% | · | · | |
| ROA (TTM) | 14.6%média 5A ≈16.9% | ≈16.9% | · | · | |
| ROE (TTM) | 17.2%média 5A ≈17.4% | ≈17.4% | · | · | |
| ROIC | 17.7%média 5A ≈15.7% | ≈15.7% | · | · |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | DOCS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 6.1média 5A ≈6.9 | ≈6.9 | · | · | |
| Quick Ratio (Índice de Liquidez Seca) | 2.3média 5A ≈1.9 | ≈1.9 | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | DOCS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 13.1%média 5A ≈26.9% | ≈26.9% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 15.4%média 5A ≈21.9% | ≈21.9% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 25.5% | · | · | · | |
| EPS YoY | -11.7%média 5A ≈51.7% | ≈51.7% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -12.2%média 5A ≈50.2% | ≈50.2% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 22.7%média 5A ≈28.5% | ≈28.5% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | 33.6% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 20.2%média 5A ≈25.5% | ≈25.5% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | 31.3% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | DOCS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.5média 5A ≈0.5 | ≈0.5 | · | · | |
| Receivables Turnover (Giro de Contas a Receber) | 4.7média 5A ≈4.8 | ≈4.8 | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$732.8K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | $0.29 | $0.31 | -6.7% | |
| 31 de Março de 2026 | $0.26 | $0.29 | -10.0% | |
| 31 de Dezembro de 2025 | $0.46 | $0.45 | 1.2% | |
| 30 de Setembro de 2025 | $0.45 | $0.39 | 16.4% | |
| 30 de Junho de 2025 | $0.36 | $0.31 | 17.5% | |
| 31 de Março de 2025 | $0.46 | $0.45 | 1.2% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
Balanço Patrimonial
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
Fluxo de Caixa
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
Lucratividade
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
Eficiência
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
Por Ação
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.19 | $5.73 | $4.83 | $4.98 | $4.57 | · | · | |
| Revenue / Share | $3.24 | $2.83 | $2.31 | $1.96 | $1.80 | · | · | |
| Cash Flow / Share | $1.64 | $1.36 | $0.89 | $0.84 | $0.66 | · | · | |
| Cash / Share | $1.20 | $1.11 | $0.52 | $0.81 | $0.59 | · | · | |
| EPS (TTM) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | · | 187,478,000 | 187,705,000 | 187,984,000 | · | 187,161,000 | 186,252,000 | 185,610,000 | · | 186,309,000 | 193,112,000 | 194,521,000 | · | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | · | 199,224,000 | 200,745,000 | 201,158,000 | · | 202,233,000 | 200,407,000 | 199,224,000 | · | 200,463,000 | 209,014,000 | 212,355,000 | · | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
Balanço Patrimonial
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
Fluxo de Caixa
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
Lucratividade
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
Liquidez e Solvência
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
Eficiência
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
Por Ação
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.09 | · | $5.29 | $5.82 | $5.47 | · | $5.50 | $5.15 | $4.92 | · | $4.64 | $4.62 | $5.09 | · | $4.81 | $4.57 | |
| Revenue / Share | $0.82 | · | $0.93 | $0.84 | $0.73 | · | $0.83 | $0.68 | $0.64 | · | $0.67 | $0.54 | $0.51 | · | $0.54 | $0.48 | |
| Cash Flow / Share | $0.22 | · | · | · | $0.31 | · | · | · | $0.21 | · | · | · | $0.27 | · | · | · | |
| Cash / Share | $1.52 | · | $0.35 | $0.90 | $0.73 | · | $0.88 | $0.99 | $0.60 | · | $0.66 | $0.57 | $1.58 | · | $0.71 | $0.38 | |
| EPS (TTM) | $0.84 | · | $1.20 | $1.26 | $1.17 | · | $1.00 | $0.87 | $0.80 | · | $0.67 | $0.59 | $0.56 | · | $0.56 | $0.66 |
Avaliação (TTM)
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $638M | $621M | $590M | · | $550M | $517M | $494M | · | $468M | $448M | $437M | · | $402M | $384M | |
| Net Income TTM | $167M | · | $239M | $253M | $235M | · | $201M | $174M | $161M | · | $138M | $123M | $119M | · | $119M | $141M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 24.7 | · | 36.9 | 58.1 | 52.4 | · | 53.4 | 50.1 | 35.0 | · | 41.9 | 36.0 | 60.8 | · | 59.9 | 45.8 | |
| P/S | 5.7 | · | 12.8 | 22.1 | 19.5 | · | 18.2 | 15.7 | 10.5 | · | 11.1 | 8.9 | 15.2 | · | 16.1 | 15.1 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| Earnings Yield | 4.0% | · | 2.7% | 1.7% | 1.9% | · | 1.9% | 2.0% | 2.9% | · | 2.4% | 2.8% | 1.7% | · | 1.7% | 2.2% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Receita | $645M | $570M | $475M | $419M | $344M |
| Margem Bruta % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| Margem Operacional % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| Lucro líquido | $196M | $223M | $148M | $113M | $155M |
| EPS Diluído | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| Índice de Liquidez Seca | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $326M | $273M | $184M | $178M | $125M |
Investidores institucionais (13F) 410 declarantes · $3.3B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 44 (-51 vs trimestre anterior) | 100 (-12 vs trimestre anterior) | 132 (-36 vs trimestre anterior) | 147 (+21 vs trimestre anterior) | +3.0M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $588.281.276 | 13.285.485 | 17,59% | Ações |
| BlackRock, Inc. | $296.729.585 | 14.307.116 | 8,87% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132.468.433 | 6.387.099 | 3,96% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $123.971.960 | 5.977.433 | 3,71% | Ações |
| D. E. Shaw & Co., Inc. | $122.826.179 | 5.922.188 | 3,67% | Ações |
| TWO SIGMA INVESTMENTS, LP | $96.385.189 | 4.647.309 | 2,88% | Ações |
| STATE STREET CORP | $87.334.253 | 4.210.909 | 2,61% | Ações |
| GOLDMAN SACHS GROUP INC | $84.762.882 | 4.086.928 | 2,53% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $79.848.140 | 3.849.310 | 2,39% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $65.022.244 | 3.135.113 | 1,94% | Ações |
| DEUTSCHE BANK AG\ | $60.011.895 | 2.893.534 | 1,79% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $59.184.680 | 2.853.649 | 1,77% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $55.840.936 | 2.692.427 | 1,67% | Ações |
| Carmignac Gestion | $48.861.366 | 2.355.900 | 1,46% | Ações |
| FEDERATED HERMES, INC. | $48.345.085 | 2.331.007 | 1,45% | Ações |
| MORGAN STANLEY | $46.575.609 | 2.245.689 | 1,39% | Ações |
| LOOMIS SAYLES & CO L P | $45.345.771 | 2.186.392 | 1,36% | Ações |
| Squarepoint Ops LLC | $45.090.336 | 2.174.076 | 1,35% | Ações |
| MILLENNIUM MANAGEMENT LLC | $42.902.785 | 2.068.601 | 1,28% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42.682.967 | 1.831.887 | 1,28% | Ações |
| Invesco Ltd. | $39.908.904 | 1.924.248 | 1,19% | Ações |
| Amundi | $39.467.726 | 1.902.977 | 1,18% | Ações |
| NORGES BANK | $39.178.461 | 1.889.029 | 1,17% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $37.860.213 | 1.838.767 | 1,13% | Ações |
| Gotham Asset Management, LLC | $35.523.762 | 1.712.814 | 1,06% | Ações |
| CITADEL ADVISORS LLC | $32.385.137 | 1.561.482 | 0,97% | Ações |
| Iron Triangle Partners LP | $30.401.231 | 686.568 | 0,91% | Ações |
| AXA Investment Managers S.A. | $29.339.221 | 401.083 | 0,88% | Ações |
| Walleye Capital LLC | $29.032.972 | 1.399.854 | 0,87% | Ações |
| BANK OF AMERICA CORP /DE/ | $28.029.302 | 1.351.461 | 0,84% | Ações |
| Qube Research & Technologies Ltd | $26.585.445 | 1.281.844 | 0,80% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24.611.432 | 1.186.665 | 0,74% | Ações |
| NORTHERN TRUST CORP | $24.398.059 | 1.176.377 | 0,73% | Ações |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24.081.214 | 1.161.100 | 0,72% | Ações |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $21.706.360 | 1.046.594 | 0,65% | Ações |
| CITIGROUP INC | $21.132.360 | 1.018.918 | 0,63% | Ações |
| TUDOR INVESTMENT CORP ET AL | $21.106.040 | 1.017.649 | 0,63% | Ações |
| Swedbank AB | $20.958.994 | 1.010.559 | 0,63% | Ações |
| UBS Group AG | $18.868.401 | 909.759 | 0,56% | Ações |
| JANE STREET GROUP, LLC | $18.450.221 | 889.596 | 0,55% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $17.517.170 | 844.608 | 0,52% | Ações |
| JPMORGAN CHASE & CO | $16.959.200 | 817.890 | 0,51% | Ações |
| Bank of New York Mellon Corp | $16.627.817 | 801.727 | 0,50% | Ações |
| ALGERT GLOBAL LLC | $16.161.002 | 779.219 | 0,48% | Ações |
| BANK OF NOVA SCOTIA | $15.850.607 | 764.253 | 0,47% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $14.559.480 | 702.000 | 0,44% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $13.859.558 | 668.303 | 0,41% | Ações |
| Fundsmith LLP | $13.549.940 | 653.324 | 0,41% | Ações |
| BAILLIE GIFFORD & CO | $13.349.820 | 643.675 | 0,40% | Ações |
| Glenmede Investment Management, LP | $13.095.165 | 179.018 | 0,39% | Ações |
Executivos da empresa 15 insiders · 8 diretores · 6 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jeffrey Tangney | Chief Executive Officer | 15 de Agosto de 2026 F | 2.531.955 | 0 | 0 | $0 |
| Matthew Sonefeldt | Chief Financial Officer | 15 de Agosto de 2026 F | 486.238 | 0 | 0 | $0 |
| Anna Bryson | Chief Financial Officer | 15 de Fevereiro de 2026 F | 505.549 | 0 | 0 | $0 |
| Steven L Zatz | President | 24 de Setembro de 2026 A | 204.291 | 0 | 0 | $0 |
| Siddharth Sitaram | Chief Accounting Officer | 15 de Setembro de 2026 C | 96.045 | 0 | 8 | $-419.352 |
| Craig Overpeck | Senior Vice President, Commercial Operations | 16 de Maio de 2024 S | 108.609 | 0 | 0 | $0 |
| Paul W. Jorgensen | Chief Revenue Officer | 15 de Fevereiro de 2023 F | 313.059 | 0 | 0 | $0 |
| Joseph B. Kleine | Chief Commercial Officer | 12 de Janeiro de 2022 C | 441.760 | 0 | 0 | $0 |
| Watkin Phoebe L. Yang | Conselheiro | 30 de Setembro de 2026 S | 24.744 | 0 | 1 | $-34.456 |
| Kira Scherer Wampler | Conselheiro | 1 de Setembro de 2026 C | 27.923 | 0 | 8 | $-787.360 |
| Regina M. Benjamin | Conselheiro | 27 de Agosto de 2026 A | 58.987 | 0 | 1 | $-354.200 |
| Kevin Spain | Conselheiro | 27 de Agosto de 2026 A | 11.305 | 0 | 0 | $0 |
| Timothy S Cabral | Conselheiro | 27 de Agosto de 2026 A | 11.305 | 0 | 2 | $-793.325 |
| Andreas Stavropoulos | Detentor de 10% | 28 de Junho de 2021 C | · | 0 | 0 | $0 |
| Gilbert H Kliman | · | 2 de Agosto de 2022 D | 449.960 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 80 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2,03% | 353.406 SH | 2 de Outubro de 2026 | Diário |
| LSEQ · Harbor ETF Trust | 2,02% | 14.749 NS | 31 de Julho de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,37% | 686.526 NS | 31 de Julho de 2026 | N-PORT |
| SMLL · Harbor ETF Trust | 1,35% | 9.053 NS | 31 de Julho de 2026 | N-PORT |
| RNIN · EA Series Trust | 1,13% | 98.433 NS | 31 de Julho de 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 1,03% | 525 NS | 31 de Julho de 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0,73% | 1.376.571 SH | 2 de Outubro de 2026 | Diário |
| BUL · Pacer Funds Trust | 0,49% | 30.738 NS | 31 de Julho de 2026 | N-PORT |
| IHF · iShares Trust | 0,48% | 257.076 SH | 11 de Setembro de 2026 | Diário |
| RFG · Invesco Exchange-Traded Fund Trust | 0,42% | 49.865 SH | 2 de Outubro de 2026 | Diário |
| COWG · Pacer Funds Trust | 0,33% | 349.670 NS | 31 de Julho de 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,32% | 557.810 NS | 31 de Julho de 2026 | N-PORT |
| ESUM · Strategy Shares | 0,18% | 15.942 NS | 31 de Julho de 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,15% | 132.035 SH | 19 de Agosto de 2026 | Diário |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,14% | 19.674 SH | 2 de Outubro de 2026 | Diário |
| BKSE · BNY Mellon ETF Trust | 0,12% | 5.010 NS | 31 de Julho de 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 25.655 NS | 31 de Julho de 2026 | N-PORT |
| EWUS · iShares Trust | 0,11% | 52.582 SH | 11 de Setembro de 2026 | Diário |
| VFQY · VANGUARD WELLINGTON FUND | 0,11% | 25.965 SH | 19 de Agosto de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 30.592 SH | 2 de Outubro de 2026 | Diário |
| ESSC · Strategy Shares | 0,10% | 1.770 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,10% | 39.666 SH | 11 de Setembro de 2026 | Diário |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 33.755 NS | 31 de Julho de 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,08% | 97.882 NS | 31 de Julho de 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,08% | 215.901 SH | 19 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 74.630 SH | 2 de Outubro de 2026 | Diário |
| PTMC · Pacer Funds Trust | 0,08% | 14.760 NS | 31 de Julho de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,07% | 1.747.294 SH | 19 de Agosto de 2026 | Diário |
| MIDU · Direxion Shares ETF Trust | 0,06% | 1.965 NS | 31 de Julho de 2026 | N-PORT |
| IYH · iShares Trust | 0,05% | 77.403 SH | 11 de Setembro de 2026 | Diário |
| ESML · iShares Trust | 0,05% | 56.863 SH | 11 de Setembro de 2026 | Diário |
| VFVA · VANGUARD WELLINGTON FUND | 0,05% | 21.465 SH | 19 de Agosto de 2026 | Diário |
| SMMD · iShares Trust | 0,04% | 69.284 SH | 11 de Setembro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,04% | 362.894 SH | 19 de Agosto de 2026 | Diário |
| SMDX · Tidal Trust III | 0,04% | 2.374 NS | 31 de Julho de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 57.235 NS | 31 de Julho de 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 53.898 SH | 11 de Setembro de 2026 | Diário |
| IEUS · iShares Trust | 0,03% | 67.403 SH | 11 de Setembro de 2026 | Diário |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,03% | 14.182 SH | 2 de Outubro de 2026 | Diário |
| IWS · iShares Trust | 0,03% | 193.300 SH | 11 de Setembro de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.537.722 SH | 19 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,03% | 3.033.009 SH | 19 de Agosto de 2026 | Diário |
| IWR · iShares Trust | 0,02% | 538.960 SH | 11 de Setembro de 2026 | Diário |
| RILA · Spinnaker ETF Series | 0,02% | 446 NS | 31 de Julho de 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,02% | 68.821 SH | 2 de Outubro de 2026 | Diário |
| LRND · New York Life Investments ETF Trust | 0,02% | 2.967 NS | 31 de Julho de 2026 | N-PORT |
| SCZ · iShares Trust | 0,01% | 2.047.043 SH | 11 de Setembro de 2026 | Diário |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 2.102.305 SH | 19 de Agosto de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 78.419 SH | 19 de Agosto de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,01% | 2.526 NS | 31 de Julho de 2026 | N-PORT |
| IUSG · iShares Trust | 0,01% | 114.485 SH | 11 de Setembro de 2026 | Diário |
| IWD · iShares Trust | 0,01% | 288.768 SH | 11 de Setembro de 2026 | Diário |
| IYY · iShares Trust | 0,00% | 5.691 SH | 11 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,00% | 179.485 SH | 11 de Setembro de 2026 | Diário |
| IWB · iShares Trust | 0,00% | 90.563 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 36.814 SH | 11 de Setembro de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,00% | 99.952 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3.539 NS | 31 de Julho de 2026 | N-PORT |
| IEUR · iShares Trust | 0,00% | 334.412 SH | 11 de Setembro de 2026 | Diário |
| IDEV · iShares Trust | 0,00% | 905.897 SH | 11 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,00% | 23.098 NS | 31 de Julho de 2026 | N-PORT |
| IEFA · iShares Trust | 0,00% | 4.370.632 SH | 11 de Setembro de 2026 | Diário |
| DCOR · Dimensional ETF Trust | 0,00% | 3.112 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.812 NS | 31 de Julho de 2026 | N-PORT |
| IXUS · iShares Trust | 0,00% | 862.826 SH | 11 de Setembro de 2026 | Diário |
| TILT · FlexShares Trust | 0,00% | 158 NS | 31 de Julho de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.200.411 SH | 19 de Agosto de 2026 | Diário |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 7.970.190 SH | 19 de Agosto de 2026 | Diário |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 1.396.695 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 598.294 SH | 19 de Agosto de 2026 | Diário |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 5.431.499 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,00% | 22.610 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.642 SH | 19 de Agosto de 2026 | Diário |
| VSGX · VANGUARD WORLD FUND | 0,00% | 95.335 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,00% | 29.384 SH | 19 de Agosto de 2026 | Diário |
| IJH · iShares Trust | · | 4.694.508 SH | 11 de Setembro de 2026 | Diário |
| IJK · iShares Trust | · | 774.827 SH | 11 de Setembro de 2026 | Diário |
| XJH · iShares Trust | · | 18.322 SH | 8 de Setembro de 2026 | Diário |
| ISCB · iShares Trust | · | 5.605 SH | 11 de Setembro de 2026 | Diário |
| SMLF · iShares Trust | · | 103.220 SH | 11 de Setembro de 2026 | Diário |
DOCS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
18 analistas · 2026-10-03Alvo médio $29.67 +6,2%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | · |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | · | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | · |
| GDRX | · | 30.1 | 0.57% | 3.8% | 4.8% | · |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.